IMCD is a market-leader in the sales, marketing and distribution of speciality chemicals and food ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Asia-Pacific and Americas, offering a range of comprehensive product portfolios, including innovative formulations that embrace industry trends. Listed at Euronext, Amsterdam (IMCD), IMCD realised revenues of EUR 1,715 million in 2016 with more than 1,800 employees in over 40 countries on 6 continents. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best in class solutions and provide value through expertise for about 34,000 customers and a diverse range of world-class suppliers.
IMCD Pharmaceuticals supplies the most comprehensive range of excipients, active pharmaceutical ingredients and speciality solvents, process chemicals and intermediates for chemical synthesis. Our extensive network of pharmacists, chemists and experienced formulators allows us to work closely with our clients operational and research & development departments; delivering total product solutions for today’s most demanding of manufacturing environments. IMCD’s partnership with the world’s leading suppliers brings expertise, innovation and production efficiency to the pharmaceutical, generic, OTC and nutraceutical companies across the globe.
IQVIA (NYSE: IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.